Physical Restraint of Critically Ill Patients

March 14, 2023 updated by: sara dichtwald, Meir Medical Center

Physical Restraint of Critically Ill Patients: Prevalence, Properties and Associated Delirium Score

Background: Physical restraint of patients in the intensive care unit (ICU) is a common practice, with estimated prevalence of 50% of all ICU patients, with and without invasive ventilation support(1). The prevalence of physical restraint varies between ICU's according to patient population (surgical, cardiac, trauma, burns and general intensive care patients). In mechanically ventilated patients, the physical restriction (tying the patient) is carried out frequently in addition to pharmacological treatment with analgesic and sedative medications, in order to prevent falling, self-inflicted injury or accidental removal of essential medical devices (tracheobronchial tubes, central venous infusions, drains, etc.) by the patient. In non-ventilated patients, physical restraint is often carried out in patients with delirium or cognitive decline, in addition to pharmacological anti -delirium therapy (1).

However, physical restraint has many drawbacks, including injuries to the skin and the soft tissues, blood vessels, peripheral nerves, muscle and skeleton (2). In addition, physical restraint may exacerbate symptoms of restlessness and delirium and even increase the risk of developing post-traumatic stress disorder in these patients (3,4).

Despite the high prevalence of physical restraint of ICU patients, with its disadvantages and advantages, currently there are no consensual criteria for physical restraint and the decision when and how long to use it is at the discretion of the attending physician. It is important to note that in recent years there has been a tendency to reduce the amount of sedation that mechanically ventilated patients are given, which may lead to an increase in the incidence of physical restraint of patients who are fully or partially conscious (5).

Study Overview

Status

Completed

Conditions

Detailed Description

Background: Physical restraint of patients in the intensive care unit (ICU) is a common practice, with estimated prevalence of 50% of all ICU patients, with and without invasive ventilation support(1). The prevalence of physical restraint varies between ICU's according to patient population (surgical, cardiac, trauma, burns and general intensive care patients). In mechanically ventilated patients, the physical restriction (tying the patient) is carried out frequently in addition to pharmacological treatment with analgesic and sedative medications, in order to prevent falling, self-inflicted injury or accidental removal of essential medical devices (tracheobronchial tubes, central venous infusions, drains, etc.) by the patient. In non-ventilated patients, physical restraint is often carried out in patients with delirium or cognitive decline, in addition to pharmacological anti -delirium therapy (1).

However, physical restraint has many drawbacks, including injuries to the skin and the soft tissues, blood vessels, peripheral nerves, muscle and skeleton (2). In addition, physical restraint may exacerbate symptoms of restlessness and delirium and even increase the risk of developing post-traumatic stress disorder in these patients (3,4).

Despite the high prevalence of physical restraint of ICU patients, with its disadvantages and advantages, currently there are no consensual criteria for physical restraint and the decision when and how long to use it is at the discretion of the attending physician. It is important to note that in recent years there has been a tendency to reduce the amount of sedation that mechanically ventilated patients are given, which may lead to an increase in the incidence of physical restraint of patients who are fully or partially conscious (5).

Objectives: In the first stage of our planned study (in this study) - we would like to assess the prevalence of physical restraint in ICU patients, both with and without mechanical ventilation support, their clinical characteristics and the rate of delirium among them. In the second stage of the study (in a future study) - we plan to install specific protocols for physical restraint, aiming to decrease the rate of physical restraint of patients in our ICU.

The data obtained from the first phase of the study can help us characterize the patients who require physical restraint in the ICU, which from we will attempt to generate protocols that will help us reduce the prevalence of physical restraint in the unit. For example, if the group of patients who required physical restraint tended to experience delirium more often, as measured by the RASS score, we could formulate a special protocol for the treatment of delirium in these patients, which might reduce the need for physical restraint in some cases. We can address factors that may alter the incidence of delirium, such as emphasizing the importance of renewing as soon as possible all regular patients' pharmacological therapy with antipsychotic drugs, if any, or to soon start treatment to prevent withdrawal syndrome (in case of chronic ethanol abuse, or regular benzodiazepine treatment. Alternative measures can also be used to decrease delirium prevalence, such as presence of the patient's family member, music, television, maintaining the patient's room dark at night hours, etc.), as well as other measures. The characterization of those patients is essential for the formulation of such treatment protocols.

Methods and materials:

Study type: Retrospective study based on data collection. Data will be extracted from the hospital computerized systems. The study will include all our ICU admitted patients from 1.1.2020 to 31.12.2020. About 1000 patients total.

Inclusion criteria: All patients aged 18--99 admitted to the General Intensive Care Unit from January 2020 to the end of December 2020.

Data collection: Retrospective observational data collection from hospital records and computerized systems (Chameleon system and iMDsoft software).

Collected data: Age, gender, hospital and ICU admission times, ventilation days, 28-day mortality, past medical history including chronic medication therapy, APACHE-2 score, admission lactate level, need for pressor or inotropic support, need for dialysis, need for tracheostomy, type of ICU admission (Infectious, trauma etc.), delirium score measured by the RASS score, need for physical restraint, duration of physical restraint, prevalence of self extubation, prevalence of self-inflicted injuries including falls and inadvertent retrieval of tubes or other medical devices.

Study group size: 1000 patients. Statistical analysis: All demographic and intra-patient parameters will be statistically examined by a qualified statistician depending on the type of data. The current study group will be the control group (before intervention), and the second group will be the treatment group (after intervention, i.e. after creating and installing new physical restraint protocols in the ICU) .We will use the Chi square test to analyze the discrete data and the Mann-Whitney test to analyze the continuous data.

Study Type

Observational

Enrollment (Actual)

992

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kfar Saba, Israel
        • Meir medical center Kfar Saba

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients aged 18--99 admitted to the General Intensive Care Unit from January 2020 to December 2020.

Description

Inclusion Criteria: All patients aged 18--99 admitted to the General Intensive Care Unit from January 2020 to December 2020.

-

Exclusion Criteria: None.

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group A- before implentation of physical restraint protocols
new physical restraint protocols
Group B- after implentation of physical restraint protocols
new physical restraint protocols

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of physical restraint in ICU patients
Time Frame: 1 year (January 2020 - December 2020.
To assess the prevalence of physical restraint in ICU patients (%), both with and without mechanical ventilation support
1 year (January 2020 - December 2020.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

March 14, 2023

Study Completion (Actual)

March 14, 2023

Study Registration Dates

First Submitted

February 2, 2021

First Submitted That Met QC Criteria

February 22, 2021

First Posted (Actual)

February 25, 2021

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 14, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on new physical restraint protocols

Subscribe